Literature DB >> 14755220

Effects of insulin-like growth factor-1 gene transfer on myosin heavy chains in denervated rat laryngeal muscle.

Paul W Flint1, Hideki Nakagawa, Akihiro Shiotani, Michael E Coleman, Bert W O'Malley.   

Abstract

OBJECTIVES/HYPOTHESIS: To determine whether the myotrophic activity of human insulin-like growth factor (hIGF)-1 promotes restoration of normal myosin heavy chain (MHC) composition after nerve injury, MHC composition was analyzed after hIGF-1 gene transfer in denervated rat laryngeal muscle. STUDY
DESIGN: Animal model to study effects of gene transfer on laryngeal paralysis.
METHODS: In anesthetized rats, the left recurrent and superior laryngeal nerves are cut and suture ligated. A midline thyrotomy is performed, and the thyroarytenoid muscle is injected with a polyvinyl-based formulation containing a muscle specific expression system and hIGF-1 DNA (treatment group) or saline (control group). After 30 days, animals were killed, and the thyroarytenoid muscle was removed and processed for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Densitometric measurements were obtained to determine composition of MHCs.
RESULTS: As previously described, MHC composition in denervated laryngeal muscle was characterized by a decrease in type IIB and IIL and up-regulation of IIA/IIX. Compared with controls, hIGF-1 treated animals demonstrated a significant increase in expression of type IIB and IIL and a significant decrease in expression of type IIA/X.
CONCLUSIONS: These findings suggest that the myotrophic effect of hIGF-1 gene transfer results in normalization of MHC composition in denervated muscle, with suppression of type IIA/X MHC and promotion of type IIL expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755220     DOI: 10.1097/00005537-200402000-00035

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Otolaryngology-head and neck surgery at Johns Hopkins: The first 100 years (1914-2014).

Authors:  Howard W Francis; Ira Papel; Ioan Lina; Wayne Koch; David Tunkel; Paul Fuchs; Sandra Lin; David Kennedy; Robert Ruben; Fred Linthicum; Bernard Marsh; Simon Best; John Carey; Andrew Lane; Patrick Byrne; Paul Flint; David W Eisele
Journal:  Laryngoscope       Date:  2015-08-22       Impact factor: 3.325

2.  IGF-I activates the mouse type IIb myosin heavy chain gene.

Authors:  R Andrew Shanely; Kevin A Zwetsloot; Thomas E Childs; Simon J Lees; Richard W Tsika; Frank W Booth
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-05       Impact factor: 4.249

3.  Reconstructive procedures for impaired upper airway function: laryngeal respiration.

Authors:  Andreas Müller
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 4.  Gene Therapy for Recurrent Laryngeal Nerve Injury.

Authors:  Koji Araki; Hiroshi Suzuki; Kosuke Uno; Masayuki Tomifuji; Akihiro Shiotani
Journal:  Genes (Basel)       Date:  2018-06-25       Impact factor: 4.096

5.  The Regenerative Effects of c-Met Agonistic Antibodies in Vocal Fold Atrophy.

Authors:  Hyunsu Choi; Seung-Shin Yu; Jiwon Choi; Choung-Soo Kim
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

Review 6.  Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury.

Authors:  Benjamin R Slavin; Karim A Sarhane; Nicholas von Guionneau; Phillip J Hanwright; Chenhu Qiu; Hai-Quan Mao; Ahmet Höke; Sami H Tuffaha
Journal:  Front Bioeng Biotechnol       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.